Skip to main content
. 2018 Jul 12;14(4):492–497. doi: 10.3988/jcn.2018.14.4.492

Table 1. Demographic data of and clinical manifestation in patients with PKD and PNKD.

PKD (n=40) PNKD (n=14) p-value
Sex (male:female) 31:9 6:8 0.023*
Family history (n, %) 15 (37.5) 1 (7.1) 0.043*
Onset age (years, mean±SD) 10.1±3.77 5.4±4.95 0.001*
Presenting symptoms (n, %) 0.819
 Dystonia only 25 (62.5) 7 (50.0)
 Choreoathetosis only 10 (25.0) 4 (28.6)
 Dystonia+choreoathetosis 2 (5.0) 1 (7.1)
 Other 3 (7.5) 2 (14.3)
Duration of symptom (n, %) 0.001*
 <1 minutes 38 (95.0) 7 (50.0)
 ≥1 minutes 2 (5.0) 7 (50.0)
Localization (n, %) 0.066
 Unilateral 17 (42.5) 4 (28.6)
 Bilateral 13 (32.5) 3 (21.4)
 Alternating 5 (12.5) 6 (42.9)
 Unknown 5 (12.5) 1 (7.1)
Facial involvement (n, %) 1 (2.5) 1 (7.1) 0.473
Prodromal symptom (n, %) 14 (35.0) 3 (21.4) 0.507
Other aggravating factors (n, %) 14 (35.0) 6 (46.2) 0.522
Combined medical problem (n, %) 15 (37.5) 9 (64.3) 0.120
 Febrile seizures 4 (10.0) 0 (0.0) 0.565
 Benign infantile convulsion 5 (12.5) 0 (0.0) 0.311
 Other epilepsy 1 (2.5) 6 (42.9) 0.001*
 Others 6 (15.0) 5 (35.7) 0.129
Treatment (n, %) NA
 Medication given 37 (92.5) 13 (92.9)
 Mean treatment duration (mean±SD) 4.9±3.28 2.6±2.39
Symptom reduction (n, %) 0.202
 Symptom free 22 (64.7) 4 (30.8)
 Markedly improved 8 (23.5) 6 (46.2)
 Minimally improved 2 (5.9) 1 (7.7)
 No change or aggravated 2 (5.9) 2 (15.4)

*p<0.05, Some patients have two or more comorbidities.

NA: not available, PKD: paroxysmal kinesigenic dyskinesia, PNKD: paroxysmal nonkinesigenic dyskinesia.